RA Capital leads $125M for Janux in VC's latest crossover bid
Four months ago, only a short list of people had ever heard of Janux Therapeutics. Today, they have a partnership with Merck, $212 million in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
